In addition, CB1 and CB2 receptors were highly expressed in non-Hodgkin’s lymphoma, and CB1 in mantle cell lymphoma compared to reactive lymph nodes [83,104]. This evidence concerns the gene CNR1 and mantle cell lymphoma.